30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Marker Therapeutics Inc (MRKR)

Track

Stock chart
Ticker: MRKR Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
ELMS STEVE
1 purchase — total 35,472 USD
Buy 23 Dec 2024
Value US$3,137,160.78 | Price 68.90 | Shares 56,912
Buy 23 Dec 2024
Value US$4,285,060.70 | Price 241.20 | Shares 35,258
Buy 16 Mar 2021
Value US$249,987.50 | Price 17.50 | Shares 14,285
Buy 16 Mar 2021
Value US$1,999,999.75 | Price 1.75 | Shares 1,142,857
Buy 16 Mar 2021
Value US$999,999.00 | Price 1.75 | Shares 571,428
Buy 16 Mar 2021
Value US$9,999,998.75 | Price 1.75 | Shares 5,714,285
Buy 16 Mar 2021
Value US$9,999,998.75 | Price 1.75 | Shares 5,714,285
Buy 16 Mar 2021
Value US$9,999,998.75 | Price 1.75 | Shares 5,714,285
Buy 16 Mar 2021
Value US$9,999,998.75 | Price 1.75 | Shares 5,714,285
Buy 16 Mar 2021
Value US$2,999,998.75 | Price 1.75 | Shares 1,714,285
Buy 16 Mar 2021
Value US$249,999.75 | Price 1.75 | Shares 142,857
Buy 16 Mar 2021
Value US$9,999,998.75 | Price 1.75 | Shares 5,714,285
Buy 16 Mar 2021
Value US$9,999,998.75 | Price 1.75 | Shares 5,714,285
Buy 16 Mar 2021
Value US$9,999,998.75 | Price 1.75 | Shares 5,714,285
Buy 16 Mar 2021
Value US$9,999,998.75 | Price 1.75 | Shares 5,714,285
Buy 16 Mar 2021
Value US$9,999,998.75 | Price 1.75 | Shares 5,714,285
Buy 16 Mar 2021
Value US$9,999,998.75 | Price 1.75 | Shares 5,714,285
Buy 14 Aug 2019
Value US$46,200.00 | Price 4.62 | Shares 10,000
Buy 14 May 2018
Value US$3,120,000.00 | Price 2.40 | Shares 1,300,000
Sale 23 Mar 2011
Value US$19,200.00 | Price 0.12 | Shares 160,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-26 2024-12-23 B Purchase
2.6
ELMS STEVE
Non-Executive Director
56,912 +20.9%
68.90
US$3,137,161 		56,912 +20.9% 68.90 US$3,137,161
2024-12-23 2024-12-23 B Purchase
1.2
New Enterprise Associates 16, L.P.
Large shareholder
35,258 +47.7%
241.20
US$4,285,061 		35,258 +47.7% 241.20 US$4,285,061
2023-06-08 2021-03-16 B Purchase
3.6
Eansor Norman David
Non-Executive Director
264 -21.1%
439.70
US$3,817,317 		264 -21.1% 439.70 US$3,817,317
2021-03-18 2021-03-16 B Purchase
2.6
ELMS STEVE
Non-Executive Director
1,142,857 +57.1%
1.75
US$2,000,000 		1,142,857 +57.1% 1.75 US$2,000,000
2021-03-18 2021-03-16 B Purchase
3.2
Vera Juan

Chief Development Officer

Officer
571,428 +28.7%
1.75
US$999,999 		571,428 +28.7% 1.75 US$999,999
2021-03-18 2021-03-16 B Purchase
2.1
Sonsini Peter W.
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
2.4
SANDELL SCOTT D
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
2.7
Makhzoumi Mohamad
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
1.2
New Enterprise Associates 16, L.P.
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
Wilson John Robert
Non-Executive Director
1,714,285 +28.2%
1.75
US$2,999,999 		1,714,285 +28.2% 1.75 US$2,999,999
2021-03-18 2021-03-16 B Purchase
Hoang Peter L.

President and CEO

Executive Director
142,857 +75.3%
1.75
US$250,000 		142,857 +75.3% 1.75 US$250,000
2021-03-18 2021-03-16 B Purchase
2.5
BASKETT FOREST
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
2.6
Florence Anthony A. Jr.
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
2.1
MAKOWER JOSHUA
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
3.9
Walker Paul Edward
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
3.5
Chang Carmen
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2021-03-18 2021-03-16 B Purchase
1.5
Behbahani Ali
Large shareholder
5,714,285 +114.3%
1.75
US$9,999,999 		5,714,285 +114.3% 1.75 US$9,999,999
2019-08-15 2019-08-14 B Purchase Hoang Peter L.

President and CEO

Executive Director
10,000 +5.6%
4.62
US$46,200 		10,000 +5.6% 4.62 US$46,200
2018-05-16 2018-05-14 B Purchase Eastern Capital LTD Large shareholder
1,300,000 +32.5%
2.40
US$3,120,000 		1,300,000 +32.5% 2.40 US$3,120,000
2011-04-05 2011-03-23 S Sale CORIN DENIS

President and CFO

Executive Director
160,000 -54.2%
0.12
US$19,200 		160,000 -54.2% 0.12 US$19,200
Explore more

More insider trading research around Marker Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America